[Bone and joint diseases in children. Bisphosphonates in osteogenesis imperfecta]

Sumie Yamashita1

  • 1Department of Pediatrics, Osaka Koseinenkin Hospital.

Clinical Calcium
|June 2, 2010
PubMed

Insights

Osteogenesis imperfecta (OI) is a genetic bone disorder. Bisphosphonates like pamidronate and zolendronate are used for treatment, with newer options showing promise but needing more research on optimal use and long-term safety.

Area of Science:

  • Medical Genetics
  • Pharmacology
  • Orthopedics

Background:

  • Osteogenesis imperfecta (OI) is a genetic disorder causing bone fragility and low bone density.
  • Current treatments for moderate to severe OI include cyclic intravenous pamidronate.
  • Oral bisphosphonates offer benefits and convenience for mild OI cases.

Purpose of the Study:

  • To review the current treatment landscape for Osteogenesis Imperfecta.
  • To evaluate the efficacy and safety of newer bisphosphonate therapies.
  • To identify areas for future research in OI management.

Main Methods:

  • Literature review of studies on bisphosphonate treatment for OI.
  • Analysis of clinical trial data for intravenous and oral bisphosphonates.
  • Comparison of pamidronate and zolendronate efficacy and safety profiles.

Main Results:

  • Intravenous pamidronate is the standard for moderate to severe OI.
  • Oral bisphosphonates are effective for mild OI.
  • Short-term data suggest intravenous zolendronate is safe and effective in children with OI, comparable to pamidronate.

Conclusions:

  • Bisphosphonates are crucial in managing Osteogenesis Imperfecta.
  • Newer bisphosphonates like zolendronate show potential but require further investigation.
  • Optimal dosing, treatment duration, and long-term safety of novel bisphosphonates need extensive study.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
What is the Skeletal System?01:02

What is the Skeletal System?

Overview
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
The Functions of the Skeletal System01:22

The Functions of the Skeletal System

The most apparent functions of the skeletal system are support, protection, and movement. However, bone tissue also performs several other critical metabolic functions. For one, the bone matrix acts as a reservoir for a number of minerals important to the functioning of the body, especially calcium and phosphorus. These minerals, present in the bone tissue, can be released back into the bloodstream when required. Calcium ions, for example, are essential for muscle contractions and controlling...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...